New SEC Form D filing
OS Therapies Inc, 2026-10-23
A new SEC Form D private-offering notice from Grasonville, MD, a $12,282,478 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing HER2-targeted immunotherapies for osteosarcoma and other solid tumors
New filing todayFiled to raise $12,282,478First money in 2026-10-15Raised so far $7,172,429HQ (as filed) Grasonville, MDSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified ostherapies.com↗Named in the filing 9 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR sourceThe Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.